Status:
UNKNOWN
Impella in Cardiogenic Shock Registry
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Shock, Cardiogenic
Eligibility:
All Genders
Brief Summary
The purpose of the study is to evaluate the safety, efficacy and clinical usefulness of a mechanical support strategy with the impella device.
Detailed Description
In the last two decades mortality from acute coronary syndromes has decreased dramatically thanks to aggressive use of coronary revascularization techniques. In cardiogenic shock however, a dramatique...
Eligibility Criteria
Inclusion
- • Patients admitted for cardiogenic shock (defined as SBP \<90 mmHg without vasopressors/inotropics or elevated serum lactate).
- AND
- • Treatment with Impella device
Exclusion
- None
Key Trial Info
Start Date :
January 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06007963
Start Date
January 29 2021
End Date
January 1 2024
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven, Gasthuisberg
Leuven, Belgium